ALAN LOCKWOOD: Open Payments
NPI 1639702061 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 34 payments from 13 companies in 2025. Trend: 2023 $93 · 2024 $406 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $303 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Janssen Biotech, Inc. | 4 | $76 |
| Genmab U.S., Inc. | 2 | $60 |
| EMD Serono, Inc. | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
| Adaptive Biotechnologies Corporation | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Caris MPI, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $23 |
Products named: EPKINLY, IMBRUVICA, TECVAYLI, ZEPZELCA, clonoSEQ, LUTATHERA, Tivdak, ULTOMIRIS.
Industry payments across OH — which companies pay providers there.
